BEIJING (AP) — China has unveiled draft regulations on gene editing and other potentially risky biomedical technologies after a Chinese scientist's ...
News
- China drafts rules on biotech after gene-editing scandal
- Celcuity Reports Fourth Quarter and Full Year 2018 Financial Results
We signed a clinical trial agreement with Puma Biotechnology, Inc. and ... the Miami Breast Cancer Conference, and the San Antonio Breast Cancer ...
- Rapamycin Holdings Changes Name to Emtora Biosciences, Hires New CEO
San Antonio — Rapamycin Holdings, a life sciences business working to commercialize a new formulation of an immunosuppressant as a prostate ...
- Rapamycin Holdings, Inc. Rebrands to Emtora Biosciences as New Leadership Focuses Company ...
SAN ANTONIO--(BUSINESS WIRE)--Feb 26, 2019--Rapamycin Holdings, ... The rebrand to Emtora Biosciences enables a dynamic and meaningful ...
- Eni (E) Initiates Construction of 31MW Photovoltaic Plant
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They're also finding ...